title: Interference of low-molecular substances with the thioflavin-T fluorescence assay of amyloid fibrils.
abstract: Abnormal fibrillization of amyloidogenic peptides/proteins has been linked to various neurodegenerative diseases such as Alzheimer's and Parkinson's disease as well as with type-II diabetes mellitus. The kinetics of protein fibrillization is commonly studied by using a fluorescent dye Thioflavin T (ThT) that binds to protein fibrils and exerts increased fluorescence intensity in bound state. Recently, it has been demonstrated that several low-molecular weight compounds like Basic Blue 41, Basic Blue 12, Azure C, and Tannic acid interfere with the fluorescence of ThT bound to Alzheimers' amyloid-β fibrils and cause false positive results during the screening of fibrillization inhibitors. In the current study, we demonstrated that the same selected substances also decrease the fluorescence signal of ThT bound to insulin fibrils already at submicromolar or micromolar concentrations. Kinetic experiments show that unlike to true inhibitors, these compounds did neither decrease the fibrillization rate nor increase the lag-period. Absence of soluble insulin in the end of the experiment confirmed that these compounds do not disaggregate the insulin fibrils and, thus, are not fibrillization inhibitors at concentrations studied. Our results show that interference with ThT test is a general phenomenon and more attention has to be paid to interpretation of kinetic results of protein fibrillization obtained by using fluorescent dyes.
authors.affiliation: Department of Gene Technology, Tallinn University of Technology, Akadeemia 15, 12618, Tallinn, Estonia.
authors.forename: Andra
authors.initials: A
authors.lastname: Noormägi
authors.forename: Kateryna
authors.initials: K
authors.lastname: Primar
authors.forename: Vello
authors.initials: V
authors.lastname: Tõugu
authors.forename: Peep
authors.initials: P
authors.lastname: Palumaa
mesh_terms: D000682:Amyloid / Q000032:analysis* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000032:analysis / Q000378:metabolism; D001399:Azure Stains / Q000009:adverse effects / Q000378:metabolism; D052160:Benzothiazoles; D001681:Biological Assay; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000378:metabolism; D005189:False Positive Reactions; D005456:Fluorescent Dyes / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000032:analysis* / Q000378:metabolism; D007700:Kinetics; D019636:Neurodegenerative Diseases / Q000175:diagnosis* / Q000378:metabolism; D017433:Protein Structure, Secondary; D013050:Spectrometry, Fluorescence; D013634:Tannins / Q000009:adverse effects / Q000378:metabolism; D013844:Thiazoles / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D000682:Amyloid; D016229:Amyloid beta-Peptides; D001399:Azure Stains; D052160:Benzothiazoles; D005456:Fluorescent Dyes; D007328:Insulin; D013634:Tannins; D013844:Thiazoles; C009462:thioflavin T; C045363:Azure C